ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1054

Ballooning Complexity of Dialysis Quality Measures over a Quarter Century

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Vidhun, Tanya, Harvard University, Cambridge, Massachusetts, United States
  • Trivedi, Amal, Brown University, Providence, Rhode Island, United States
  • Lin, Eugene, Keck Medicine of USC, Los Angeles, California, United States
Background

Medicare assesses dialysis quality using the Quality Incentive Program (QIP), which financially penalizes poor performance, and Dialysis Facility Compare (DFC), which assigns each facility a publicly available 5-star rating. Despite the consequences of these programs on reimbursement and public reporting, little is known about the overlap, stability, and consistency of the programs.

Methods

From Medicare’s promulgated rules and measure specifications, we mapped the dialysis quality measure landscape and changes over time from 2001-2026. We categorized measures by beneficiary inclusion, risk adjustment model, program inclusion in the QIP, DFC or both, and assessed measure alignment across both programs. We assessed annual changes to measures, including additions, removals, and modifications.

Results

DFC grew from 3 measures in 2001 to 19 measures in 2026. QIP similarly expanded from 3 measures in 2010 to 15 measures in 2026 (Figure 1). Measure alignment between the two programs shrank over time. By 2026, less than 50% of measures (11 out of 23) overlapped between the two programs, and 3 of those 11 (27%) had conflicting specifications. QIP measures saw little stability year-to-year (Figure 2). In only 3 of the last 11 years was the QIP identical to the previous year. There was only year (2024) where >75% of measures were stable for at least 4 years.

Conclusion

There is substantial year-to-year heterogeneity in dialysis quality measures with little alignment across programs. Policymakers should consider harmonizing and maintaining stability in measures to increase their relative effectiveness in driving quality improvement.

The Dialysis Quality Measure Landscape

Changes to QIP Program

Funding

  • NIDDK Support